Alexia S Collins, Tristi M Edwards, Laura N Uwakwe, Mary F Lee-Wong, Jessica Perfetto, Sharon A Glick
{"title":"Recognizing and managing linear morphea in a pediatric patient with skin of color.","authors":"Alexia S Collins, Tristi M Edwards, Laura N Uwakwe, Mary F Lee-Wong, Jessica Perfetto, Sharon A Glick","doi":"10.1097/JW9.0000000000000290","DOIUrl":"10.1097/JW9.0000000000000290","url":null,"abstract":"<p><p>Linear morphea is the most prevalent subtype of morphea in pediatric patients and poses a significant clinical concern because of its potential to involve deeper tissues, including muscle, fascia, and bone. If not identified and treated promptly, this can result in long-term complications such as joint contractures, limb length discrepancies, and functional impairment. Diagnosing and managing morphea in children with skin of color presents unique challenges, as hallmark inflammatory signs like erythema may be less visible or absent altogether, leading to delays in diagnosis and difficulties in monitoring disease activity. In darker skin tones, active lesions may instead present as hyperpigmented or hypopigmented patches, which can mimic other common pediatric dermatoses. These diagnostic limitations underscore the need for heightened clinical suspicion and tailored diagnostic strategies in this population. While consensus-based treatment algorithms exist for pediatric morphea, these guidelines are largely derived from studies in lighter skin types and do not address diagnostic and monitoring challenges unique to patients with skin of color. Additional research is needed to develop inclusive guidelines that address these gaps and improve long-term disease control. Herein, we present the case of linear morphea in a 5-year-old African American child, highlighting the diagnostic, therapeutic, and monitoring challenges specific to pediatric patients with skin of color.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 3","pages":"e290"},"PeriodicalIF":3.0,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13322471/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148371054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jaclyn Roland-McGowan, Ella Jeffreys, Kevin P White, Erin L Foster
{"title":"Vulvar fixed drug eruption: a rare manifestation of cutaneous adverse drug reaction.","authors":"Jaclyn Roland-McGowan, Ella Jeffreys, Kevin P White, Erin L Foster","doi":"10.1097/JW9.0000000000000278","DOIUrl":"10.1097/JW9.0000000000000278","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e278"},"PeriodicalIF":3.0,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308891/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347353","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Common misconceptions of proper sun protection practices among women wearing hijab in Saudi Arabia: a literature review.","authors":"Amina Tariq","doi":"10.1097/JW9.0000000000000263","DOIUrl":"10.1097/JW9.0000000000000263","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e263"},"PeriodicalIF":3.0,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308895/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Comparative efficacy and skin barrier effects of topical dapsone and benzoyl peroxide in acne vulgaris.","authors":"Pinthisa Nisagornsen, Salinee Rojhirunsakool, Nanticha Faromkao, Pintusorn Kungvalpivat","doi":"10.1097/JW9.0000000000000266","DOIUrl":"10.1097/JW9.0000000000000266","url":null,"abstract":"<p><strong>Background: </strong>Acne is commonly treated with topical agents such as benzoyl peroxide (BP), which is effective but limited by side effects. Topical dapsone may offer a better-tolerated alternative.</p><p><strong>Objective: </strong>To compare the efficacy and safety of topical 5% dapsone versus 2.5% BP in mild-to-moderate acne.</p><p><strong>Materials and methods: </strong>Fifty patients with mild-to-moderate acne were enrolled and randomized. Outcomes included reduction in acne lesion count (inflammatory, noninflammatory, and total), Global Acne Assessment Score (GAAS), patient satisfaction, transepidermal water loss, and side effects.</p><p><strong>Results: </strong>Forty-four patients completed 12 weeks of treatment (20 with 5% dapsone, 24 with 2.5% BP). Both treatments significantly reduced acne lesions and GAAS scores. Dapsone 5% was more effective in reduction of inflammatory lesions, whereas BP 2.5% was more effective for noninflammatory lesions. Dapsone 5% also achieved a faster reduction in total acne lesions and GAAS scores. Transepidermal water loss increased significantly with BP 2.5%, but not with dapsone 5%. Local side effects, particularly pruritus and erythema, were more frequent with BP.</p><p><strong>Limitations: </strong>Single-center design and short study duration.</p><p><strong>Conclusion: </strong>Topical 5% dapsone is an effective and well-tolerated option for mild-to-moderate acne, particularly for inflammatory lesions, and may serve as an alternative for patients intolerant to standard therapies.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e266"},"PeriodicalIF":3.0,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Francisco Martins, José Carlos Cardoso, Joana Calvão
{"title":"Intermammary ulcer in an elderly woman.","authors":"Francisco Martins, José Carlos Cardoso, Joana Calvão","doi":"10.1097/JW9.0000000000000273","DOIUrl":"10.1097/JW9.0000000000000273","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e273"},"PeriodicalIF":3.0,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308893/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347387","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Glossed over: the increasing importance of ultraviolet-cured gel nail polish in allergic contact dermatitis.","authors":"Aalia Syed, Brandon Tan, Dedee F Murrell","doi":"10.1097/JW9.0000000000000267","DOIUrl":"10.1097/JW9.0000000000000267","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e267"},"PeriodicalIF":3.0,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308931/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Eryn Patin, Kathyana P Santiago Mangual, Arianne Shadi Kourosh, Young H Lim, Sandy Tsao
{"title":"Facial restoration of morphea and Parry-Romberg syndrome with resilient hyaluronic acid: a case report.","authors":"Eryn Patin, Kathyana P Santiago Mangual, Arianne Shadi Kourosh, Young H Lim, Sandy Tsao","doi":"10.1097/JW9.0000000000000279","DOIUrl":"10.1097/JW9.0000000000000279","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e279"},"PeriodicalIF":3.0,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308920/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carolin Schröder, Karla Feodorovici, Laura Tascón Padrón, Lucia A Otten, Matthias Bernhard Stope, Alexander Mustea
{"title":"Noninvasive physical plasma in vulvar lichen sclerosus: a prospective pilot study.","authors":"Carolin Schröder, Karla Feodorovici, Laura Tascón Padrón, Lucia A Otten, Matthias Bernhard Stope, Alexander Mustea","doi":"10.1097/JW9.0000000000000277","DOIUrl":"10.1097/JW9.0000000000000277","url":null,"abstract":"<p><strong>Background: </strong>Lichen sclerosus (LS) is a chronic inflammatory dermatosis predominantly affecting the anogenital region and is associated with significant impairment of quality of life. High-potency topical corticosteroids are the standard of care; however, some patients show inadequate response or experience relapse. Noninvasive physical plasma (NIPP) is an emerging therapeutic modality with antimicrobial and anti-inflammatory properties, but its role in LS remains unclear.</p><p><strong>Objective: </strong>To evaluate the safety, tolerability, and preliminary efficacy of NIPP as an adjunctive treatment in patients with vulvar LS refractory to topical corticosteroids.</p><p><strong>Methods: </strong>This prospective single-arm pilot study included 5 women with histologically confirmed LS and/or chronic vulvar inflammation with persistent symptoms despite topical corticosteroid therapy. Patients received at least 3 NIPP sessions (plasma care, terraplasma medical GmbH), each applied for 1 minute over a 4 × 4 cm area at intervals of 4 to 6 weeks, while continuing standard topical treatment. Clinical assessment, photographic documentation, and patient-reported outcomes using a study-specific questionnaire were collected at baseline, at each session, and at follow-up 4 to 6 weeks after the final treatment.</p><p><strong>Results: </strong>The median age was 46 years, and the median disease duration was 3 years. No consistent improvement in symptoms or clinical findings was observed following NIPP treatment. Three patients indicated willingness to undergo NIPP again, and 1 patient reported improvement in sexual well-being. No severe adverse events occurred. Treatment was generally well tolerated; however, 1 patient discontinued participation due to treatment-related discomfort.</p><p><strong>Limitations: </strong>The main limitations are small sample size, lack of a control group, and heterogeneity in disease duration and prior/current treatments.</p><p><strong>Conclusion: </strong>In this pilot study, adjunctive NIPP did not demonstrate consistent clinical benefit in vulvar LS but appeared safe and well-tolerated. Larger controlled studies are required to further assess its therapeutic potential.</p>","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e277"},"PeriodicalIF":3.0,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A case of inflammatory linear verrucous epidermal nevus of the vulva.","authors":"Monika Bapna, Sarah Corley","doi":"10.1097/JW9.0000000000000269","DOIUrl":"10.1097/JW9.0000000000000269","url":null,"abstract":"","PeriodicalId":53478,"journal":{"name":"International Journal of Women''s Dermatology","volume":"12 2","pages":"e269"},"PeriodicalIF":3.0,"publicationDate":"2026-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13308922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148347374","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}